EUVIMEDEUVIMED entdecken
Crossref

GLYMPHATIC SYSTEM DISORDERS IN ALZHEIMER’S DISEASE

Marta Koźmińczuk, Julia Gąsiorowska, Sara Urszula Haładyj, Marta Shved, Natalia Struzik, Marta Nowakowska-Kotas

Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS · 17.06.2026

DOI: 10.5114/irons/217100 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS, online erschienen am 17.06.2026. Verfasst von Marta Koźmińczuk und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dysfunction of the glymphatic system (GS) impairs the removal of metabolites from the central nervous system, promoting neurotoxic change and the progression of Alzheimer’s disease (AD). AD is characterised by the abnormal accumulation of neurotoxic amyloid-b (Ab) and tau proteins within the brain.

Aim

In this review, we aim to summarize current knowledge on GS dysregulation and its association with AD development and progression. Material and methods A literature search was carried out using five scientific databases to identify English-language studies on GS alterations in AD in humans published within the last five years. After screening and eligibility assessment, 44 articles were included.

Results

According to our research AD appears to be associated with GS impairment. The most frequently reported indicators of GS dysfunction were the analysis along the perivascular space (ALPS) index, choroid plexus (CP) enlargement, and enlarged perivascular spaces (EPVS). A low ALPS-index is used as an indicator of GS dysfunction. Patients with AD show significantly reduced ALPS-index and an increased number of EPVS than controls. CP plays a crucial role in Ab clearance, and CP enlargement is considered a manifestation of its dysfunction, as observed in patients with AD. GS dysfunction may also be indicated by genetic factors and physiological modulations.

Conclusions

The review demonstrated that dysfunction of the GS disrupts the drainage of cerebrospinal and interstitial fluid, leading to impaired removal of metabolites, accumulation of Ab, and progressive neurodegeneration in AD.

Zitieren

APA

Koźmińczuk, M., Gąsiorowska, J., Haładyj, S. U., Shved, M., Struzik, N., & Nowakowska-Kotas, M. (2026). GLYMPHATIC SYSTEM DISORDERS IN ALZHEIMER’S DISEASE. Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS. https://doi.org/10.5114/irons/217100

Vancouver

Koźmińczuk M, Gąsiorowska J, Haładyj SU, Shved M, Struzik N, Nowakowska-Kotas M. GLYMPHATIC SYSTEM DISORDERS IN ALZHEIMER’S DISEASE. Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS. 2026. doi:10.5114/irons/217100

BibTeX
@article{Komiczuk2026,
  author = {Koźmińczuk, Marta and Gąsiorowska, Julia and Haładyj, Sara Urszula and Shved, Marta and Struzik, Natalia and Nowakowska-Kotas, Marta},
  title = {GLYMPHATIC SYSTEM DISORDERS IN ALZHEIMER’S DISEASE},
  journal = {Issues of Rehabilitation Orthopaedics Neurophysiology and Sport Promotion – IRONS},
  year = {2026},
  doi = {10.5114/irons/217100}
}
Kostenlos starten →